| 영문 | deoxyribonucleic acid (DNA) | 한글 | 데옥시리보핵산 |
|---|---|---|---|
| 설명 | 핵산의 일종으로 DNA라고도 한다. Deoxyribonucleotide의 중합체이며 유전자의 화학적 본체이다. RNA바이러스 이외의 모든 생물은 DNA를 유전자로 지니고 있다. 디옥시리보뉴클레오티드(deoxyribonucleotide)는 염기와 당(2'-deoxy-D-ribose)과 인산으로 이루어진다. 염기는 아데닌(adenine), 구아닌(guanine), 티민(thymine)및 시토신(cytosine)의 4가지이며, 이것은 당에 부착되어 있다. 인산 역시 당의 한 부분에 부착되어 있다. 이 deoxyribonucleotide의 당은 다른 deoxy- ribonucleotide의 당과 인산을 사이에 놓고 결합을 하게 되어 하나의 긴 사슬을 형성하게 된다. 즉 당과 인산이 주축이 되어서 deoxyribonucleotide의 긴 사슬을 만든다. 이 deoxyribonucleotide의 사슬 두 개는 각각 deoxyribonucleotide에 부착되어 있는 염기들이 결합을 하여 두 개의 사슬이 결합되어 있는 이중나선 구조를 만들게 된다. 4가지 염기 아데닌은 티민과 결합을 하고, 시토신과 결합을 하게 된다. 즉 당과 인산은 긴 사슬을 만드는 역할을 하고 긴 사슬에 부착된 염기들의 결합에 의해서 두 개의 긴 사슬은 서로 붙어서 이중나선 구조를 만든다. DNA의 유전정보는 염기에 저장된다. 4개의 염기의 조합과 배열이 유전정보를 보관하는 하나의 암호 역할을 행하게 된다. |
||
| 영문 | DNA | 한글 | 디옥시리보핵산, 디엔에이 |
|---|---|---|---|
| 설명 | Deoxyribonucleic acid의 약어. 데옥시리보스를 구성성분으로 하는 핵산. 유전자의 화학적 본태로서 염색체에 존재한다. 데옥시리보스에 유기염기와 인산이 결합한 뉴클레오티드(구성단위)가 포스포디에스테르결합에 의해 긴사슬 중합체를 형성하며, 두 개의 긴사슬이 서로 비틀려 꼬인 나선구조를 취한다. 디옥시리보뉴클레오티드(deoxyribonucleotide)는 염기와 당(2'-deoxy-D-riboe)과 인산으로 이루어진다. 염기는 아데닌(adenine), 구아닌(guanine), 티민(thymine) 및 시토신(cytosine)의 네가지이며, 이것은 당에 부착되어 있다. 인산 역시 당의 한 부분에 부착되어 있다. 이 디옥시리보뉴클레오티드의 당은 다른 디옥시리보뉴클레오티드의 당과 인산을 사이에 놓고 결합하게 되어 하나의 긴 사슬을 형성하게 된다. |
||
| DNA | Deoxyribo-Nucleic Acid |
|---|---|
| DDS | damaged disc syndrome; dendrodendritic synaptosome; dental distress syndrome; depressed DNA synthesi... |
| DNA | deoxyribonucleic acid; did not answer |
| G1 | presynthetic gap [phase of cells prior to DNA synthesis] |
| G2 | postsynthetic gap [phase of cells following DNA synthesis] |
| R-DNA | recombinant DNA |
|---|---|
| b-DNA | Branched DNA |
| DNA MTase | DNA methytransferase |
| DNA-MG | DNA Malignancy Grade |
| DNA-PK | DNA dependent protein kinase |
IGF-II : insulin like growth factor-II의 약자. 많은 장기와 조직에 작용하여 단백 합성과 DNA, RNA의 합성을 증가시켜 세포의 수와 양을 증가
| DNA technology, recombinant | A series of procedures used to join together (recombine) DNA segments. A recombinant DNA molecule is constructed (recombined) from segments from 2 or more different DNA molecules. Under certain conditions, a recombinant DNA molecule can enter a cell and replicate there, autonomously (on its own) or after it has become integrated into a chromosome. (12 Dec 1998) |
|---|
| recombinant DNA technology | A series of procedures used to join together (recombine) DNA segments. A recombinant DNA molecule is constructed (recombined) from segments from 2 or more different DNA molecules. Under certain conditions, a recombinant DNA molecule can enter a cell and replicate there, autonomously (on its own) or after it has become integrated into a chromosome. (12 Dec 1998) |
|---|---|
| technology, recombinant DNA | A series of procedures used to join together (recombine) DNA segments. A recombinant DNA molecule is constructed (recombined) from segments from 2 or more different DNA molecules. Under certain conditions, a recombinant DNA molecule can enter a cell and replicate there, autonomously (on its own) or after it has become integrated into a chromosome. (12 Dec 1998) |
| recombinant DNA | <molecular biology> Spliced DNA formed from two or more different sources that have been cleaved by restriction enzymes and joined by ligases. (18 Nov 1997) |
| recombinant DNA molecules | A combination of DNA molecules of different origin that are joined using recombinant DNA technology. (12 Dec 1998) |
| recombinant DNA technologies | Procedures used to join together DNA segments in a cell-free system (an environment outside a cell ororganism). Under appropriate conditions, a recombinant DNA molecule canenter a cell and replicate there, either autonomously or after it hasbecome integrated into a cellular chromosome. (09 Oct 1997) |
| molecules, recombinant DNA | A combination of DNA molecules of different origin that are joined using recombinant DNA technology. (12 Dec 1998) |
| DNA molecules, recombinant | A combination of DNA molecules of different origin that are joined using recombinant DNA technology. (12 Dec 1998) |
| DNA, recombinant | Biologically active DNA which has been formed by the in vitro joining of segments of DNA from different sources. It includes the recombination joint or edge of a heteroduplex region where two recombining DNA molecules are connected. (12 Dec 1998) |
| DNA-directed DNA polymerase | <enzyme> DNA-dependent DNA polymerases found in bacteria, animal and plant cells. During the replication process, these enzymes catalyze the addition of deoxyribonucleotide residues to the end of a DNA strand in the presence of DNA as template-primer. They also possess exonuclease activity and therefore function in DNA repair. Chemical name: Deoxynucleoside-triphosphate:DNA deoxynucleotidyltransferase (DNA-directed) Registry number: EC 2.7.7.7 (12 Dec 1998) |
| antibody technology | <molecular biology> Techniques for the synthesis of polyclonal and monoclonal antibodies for use in research, diagnostics and therapeutics. (09 Feb 1998) |
| assisted reproductive technology | Originally, a range of techniques for manipulating eggs and sperm in order to overcome infertility. Encompasses drug treatments to stimulate ovulation; surgical methods for removing eggs (e.g., laparoscopy and ultrasound-guided transvaginal aspiration) and for reimplanting embryos (e.g., zygot intrafallopian transfer (or ZIFT); in vitro and in vivo fertilization (e.g., artificial insemination and gamete intrafallopian transfer (or GIFT); ex utero and in utero foetal surgery; as well as laboratory regimes for freezing and screening sperm and embryos, and micromanipulating and cloning embryos. The field's first major success came in 1978 with the birth of "test-tube baby" Louise Brown, engineered by Steptoe, Edwards, et al., of England. As the technologies spread, they increasingly are being employed for purposes beyond infertility, i.e., to reduce the risk of, or avoid passing on, hereditary disease and to select for infant sex. Further uses that would aim at improving the "quality" of offspring have been widely discussed and raise profound legal and ethical questions. See: eugenics. (05 Mar 2000) |
| recombinant | <molecular biology> A cell or an individual with a new combination of genes not found together in either parent, usually applied to linked genes. (18 Nov 1997) |
| recombinant clone | <molecular biology> Clones containing recombinant DNA molecules. See: recombinant DNA technologies. (14 Oct 1997) |
| recombinant clones | Clones containing recombinant DNA molecules. (12 Dec 1998) |
| recombinant fusion proteins | Proteins that are the result of genetic engineering. A regulatory part or promoter of one or more genes is combined with a structural gene. The fusion protein is formed after transcription and translation of the fused gene. This type of fusion protein is used in the study of gene regulation or structure-activity relationships. They might also be used clinically as targeted toxins (immunotoxins). (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|